Anjana Pillai

Speciality

Associate Professor of Medicine, University of Chicago Medicine

Personal Information

Anjana Pillai, MD, is an Associate Professor of Medicine at the University of Chicago Medicine and a board-certified gastroenterologist and transplant hepatologist who specializes in the management of chronic liver disease and hepatobiliary malignancies. Dr. Pillai is the medical director of University of Chicago’s multidisciplinary liver tumor program, the medical director of the Adult Living Donor Liver Transplant Program and the Program Director for the ACGME accredited Transplant Hepatology Fellowship.  In 2019, she co-founded the HCC Therapeutics Targets Conference (HCC-TAG), which is geared towards bringing clinicians and researchers in academia and the pharmaceutical industry for a focused interactive educational update on the most relevant advances and challenges in the diagnosis and therapy of HCC.  Dr. Pillai is also active in national societies serving on several committees of the American Society of Transplantation (AST), American Association for the Study of Liver Diseases, American Gastroenterology Association and the American College of Gastroenterology over the years. She has served on the United Network for Organ Sharing (UNOS) Regional Review Board, and now sits on the UNOS National Liver Review Board. She is the current Chair of the AST Liver and Intestinal Community of Practice (LICOP) Executive Committee. She is personally committed to promoting the career advancement and development of leadership skills for trainees and especially excited to promote women in science and medicine.